ACTA MEDICA MEDITERRANEA, cilt.36, sa.6, ss.3345-3349, 2020 (SCI-Expanded)
Introduction: Cutaneous squamous cell carcinoma (cSCC) accounts for approximately 20% of the non-melanoma cancers and is the second most common skin cancer after basal cell carcinoma. In 85%of the cases, the first metastasis site is the regional lymph nodes. However, due to lack of evidence, predictivity and utility of SLNB in cSCC remain controversial. This study aims to determine the ratio of sentinel lymph node positivity and the accuracy of this technique in high-risk cSCC patients.